Cargando…

EP4 as a Negative Prognostic Factor in Patients with Vulvar Cancer

SIMPLE SUMMARY: Within this study we investigated the expression of EP4 in vulvar cancer, its correlation with clinic-pathological parameters, its association with overall survival, and the effect oft EP4 antagonism on vulvar cancer cells, aiming to find a prognostic and potentially targetable marke...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buchholz, Anna, Vattai, Aurelia, Fürst, Sophie, Vilsmaier, Theresa, Kuhn, Christina, Schmoeckel, Elisa, Mayr, Doris, Dannecker, Christian, Mahner, Sven, Jeschke, Udo, Heidegger, Helene H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003514/ https://www.ncbi.nlm.nih.gov/pubmed/33808776 http://dx.doi.org/10.3390/cancers13061410

Ejemplares similares

Prostaglandin E2 receptor EP1 expression in vulvar cancer
por: Buchholz, Anna, et al.
Publicado: (2022)

Combined COX-2/PPARγ Expression as Independent Negative Prognosticator for Vulvar Cancer Patients
por: Ansorge, Nadine, et al.
Publicado: (2021)

LDOC1 as Negative Prognostic Marker for Vulvar Cancer Patients
por: Wanka, Giulia, et al.
Publicado: (2020)

MTA1 as negative prognostic marker in vulvar carcinoma
por: Wanka, Giulia, et al.
Publicado: (2023)

Regulatory T Cells with Additional COX-2 Expression Are Independent Negative Prognosticators for Vulvar Cancer Patients
por: Ansorge, Nadine, et al.
Publicado: (2022)

Higher CCL22+ Cell Infiltration is Associated with Poor Prognosis in Cervical Cancer Patients
por: Wang, Qun, et al.
Publicado: (2019)

Nuclear receptor corepressor (NCoR) is a positive prognosticator for cervical cancer
por: Beilner, Daniel, et al.
Publicado: (2021)

The prostaglandin receptor EP2 determines prognosis in EP3-negative and galectin-3-high cervical cancer cases
por: Dietlmeier, Sebastian, et al.
Publicado: (2020)

CCL22-Polarized TAMs to M2a Macrophages in Cervical Cancer In Vitro Model
por: Wang, Qun, et al.
Publicado: (2022)

Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer Patients
por: Wang, Qun, et al.
Publicado: (2021)

The role of EP-2 receptor expression in cervical intraepithelial neoplasia
por: Schmoeckel, Elisa, et al.
Publicado: (2020)

The Prostaglandin EP3 Receptor Is an Independent Negative Prognostic Factor for Cervical Cancer Patients
por: Heidegger, Helene, et al.
Publicado: (2017)

Expression of Progesterone Receptor A as an Independent Negative Prognosticator for Cervical Cancer
por: Garrido, Fabian, et al.
Publicado: (2023)

L-Dopa-Decarboxylase (DDC) Is a Positive Prognosticator for Breast Cancer Patients and Epinephrine Regulates Breast Cancer Cell (MCF7 and T47D) Growth In Vitro According to Their Different Expression of G(i)- Protein- Coupled Receptors
por: Tremmel, Eileen, et al.
Publicado: (2020)

Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR)
por: Ye, Yao, et al.
Publicado: (2020)

Potential of platinum-resensitization by Wnt signaling modulators as treatment approach for epithelial ovarian cancer
por: Kaltofen, Till, et al.
Publicado: (2020)

Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancer
por: Vattai, Aurelia, et al.
Publicado: (2017)

Regulation of LCoR and RIP140 expression in cervical intraepithelial neoplasia and correlation with CIN progression and dedifferentiation
por: Vogelsang, Tilman L. R., et al.
Publicado: (2020)

Lysine-specific histone demethylase 1A (LSD1) in cervical cancer
por: Beilner, Daniel, et al.
Publicado: (2020)

Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer
por: Heublein, Sabine, et al.
Publicado: (2019)

MSX1—A Potential Marker for Uterus-Preserving Therapy of Endometrial Carcinomas
por: Eppich, Simon, et al.
Publicado: (2020)

MSX1-expression during the different phases in healthy human endometrium
por: Eppich, Simon, et al.
Publicado: (2023)

PPARγ Expression Is Diminished in Macrophages of Recurrent Miscarriage Placentas
por: Kolben, Theresa Maria, et al.
Publicado: (2018)

Dopamine synthesis and dopamine receptor expression are disturbed in recurrent miscarriages
por: Gratz, Michael J, et al.
Publicado: (2018)

Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile
por: Zheng, Mingjun, et al.
Publicado: (2020)

EP3 Is an Independent Prognostic Marker Only for Unifocal Breast Cancer Cases
por: Zati Zehni, Alaleh, et al.
Publicado: (2020)

Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer
por: Vogelsang, Tilman L. R., et al.
Publicado: (2021)

The Prognostic Impact of Retinoid X Receptor and Thyroid Hormone Receptor alpha in Unifocal vs. Multifocal/Multicentric Breast Cancer
por: Zehni, Alaleh Zati, et al.
Publicado: (2021)

Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration
por: Tremmel, Eileen, et al.
Publicado: (2019)

Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9
por: Schulz, Heiko, et al.
Publicado: (2018)

Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients †
por: Schulz, Heiko, et al.
Publicado: (2017)

Identification of a Novel Tumor Microenvironment Prognostic Signature for Advanced-Stage Serous Ovarian Cancer
por: Zheng, Mingjun, et al.
Publicado: (2021)

TAAR1 induces a disturbed GSK3β phosphorylation in recurrent miscarriages through the ODC
por: Stavrou, Stavroula, et al.
Publicado: (2018)

RIPK1 and RIPK3 are positive prognosticators for cervical cancer patients and C2 ceramide can inhibit tumor cell proliferation in vitro
por: Vogelsang, Tilman L. R., et al.
Publicado: (2023)

High Galectin-7 and Low Galectin-8 Expression and the Combination of both are Negative Prognosticators for Breast Cancer Patients
por: Trebo, Anna, et al.
Publicado: (2020)

Hormone Receptor Expression in Multicentric/Multifocal versus Unifocal Breast Cancer: Especially the VDR Determines the Outcome Related to Focality
por: Zati zehni, Alaleh, et al.
Publicado: (2019)

Cytoplasmic Localization of Thyroid Hormone Receptor (TR) Alpha and Nuclear Expression of Its Isoform TRα2 Determine Survival in Breast Cancer in Opposite Ways
por: Schneider, Mariella, et al.
Publicado: (2023)

H3K4me3 Is a Potential Mediator for Antiproliferative Effects of Calcitriol (1α,25(OH)2D3) in Ovarian Cancer Biology
por: Han, Nan, et al.
Publicado: (2020)

Prostaglandin receptor EP3 regulates cell proliferation and migration with impact on survival of endometrial cancer patients
por: Zhu, Junyan, et al.
Publicado: (2017)

PD-L1 expression and survival in p16-negative and -positive squamous cell carcinomas of the vulva
por: Czogalla, Bastian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hd4noic2097pme1uvqt26fa4kf